BERLIN (Reuters) -CureVac will withdraw its first-generation COVID-19 vaccine candidate and focus on collaborating with GSK to develop second-generation mRNA vaccine technology instead, the Germany-based...
FILE PHOTO: A woman receives a dose of the Moderna vaccine against the coronavirus disease (COVID-19) at the Music Auditorium in Rome, Italy, August 5, 2021. REUTERS/Guglielmo Mangiapane/File PhotoMILAN...
Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus.
How much the manufacturers...
Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot.
The trick is...
Malaria remains a deadly disease that affects people worldwide, particularly in Africa. Caused by a parasite that can enter the human bloodstream via mosquito bite, the parasites can then infect and...
Breathe in, breathe out. That’s how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in developing intramuscular vaccines...
The allocation of COVID-19 vaccine between countries has thus far tended toward vaccine nationalism, wherein countries stockpile vaccines to prioritize access for their citizenry over equitable vaccine...
The US Food and Drug Administration (FDA) has approved Pfizer’s TicoVac vaccine for the treatment of tick-borne encephalitis (TBE). The vaccine is approved outside of United States, and more than...
This is the first tranche of the 100 million vaccines the Prime Minister pledged the UK would share within the next year at last month's G7 in Cornwall, 80 million of which will go to COVAX, a scheme...
